Clal Biotechnology | CBI - Trade Creditors


Clal Biotechnology reported ILS21.05M in Trade Creditors for its fiscal quarter ending in December of 2021.





Trade Creditors Change Date
Arca Biopharma USD 6.67M 2.5M Mar/2026
aTyr Pharma USD 3.9M 661K Sep/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.15M 371K Jun/2026
Immunic USD 11.01M 873K Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
RedHill Biopharma USD 584K 147K Jun/2026
TherapeuticsMD USD 143K 4K Jun/2024